Novo Nordisk A/S Common Stock (NVO)

About NVO

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare b…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

66,700

Website

www.novonordisk.com/

Fundamentals

1-day range

$45.41$46.21

Market cap

$208.51B

P/E (trailing)

11.40

P/E (forward)

13.30

EPS (trailing)

$26.18

Dividend yield

1.00%

Beta

1.92

Avg. volume

12.39M

Ex-dividend date

August 17, 2026

Dividend pay date

August 25, 2026

Forecasts

12 analyst ratings

Novo Nordisk A/S Common Stock Competitors

Chosen by industry and closest market cap.

• NVO

  Novo Nordisk A/S Common Stock

  $45.6

  ▼ 1.43%
  Market cap $208.51BP/E 11.40
  $224.25$409.95
• ABT

  Abbott Laboratories Common Stock

  $112.42

  ▲ 0.74%
  Market cap $185.36BP/E 35.52
  $81.97$137.49
• AZN

  AstraZeneca PLC Ordinary Shares

  $162.69

  ▼ 1.11%
  Market cap $244.97BP/E 23.44
  $10,784$15,730
• PFE

  Pfizer Inc. Common Stock

  $27.95

  ▼ 0.25%
  Market cap $142.66BP/E 35.19
  $23.58$28.75
• NVS

  Novartis AG Common Stock

  $153.79

  ▼ 0.56%
  Market cap $293.23BP/E 21.95
  $96.03$131.5
• VRTX

  Vertex Pharmaceuticals Incorporated Common Stock

  $541.72

  ▼ 1.06%
  Market cap $119.47BP/E 30.70
  $374.17$555.69
• SNY

  Sanofi ADS

  $44.82

  ▼ 0.04%
  Market cap $104.75BP/E 16.24
  $71.25$91.15

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk
  SeekingAlpha · 8/22/2026
• Novo Nordisk: The Pill That Could Close The Gap With Lilly
  SeekingAlpha · 8/21/2026
• 10 Health Care Stocks Whale Activity In Today’s Session
  Benzinga · 8/21/2026
• Novo Nordisk: The Best Value In Pharma
  SeekingAlpha · 8/19/2026
• Hims & Hers Rejects Privacy Allegations While Promising Expanded Patient Access
  Benzinga · 8/19/2026
• 'Novo Nordisk Starts Testing Lower-Doses of Its Wegovy Weight-Loss Pills' - WSJ
  Benzinga · 8/19/2026
• 4 Health Care Stocks With Whale Alerts In Today’s Session
  benzinga · 8/17/2026
• 4 Health Care Stocks With Whale Alerts In Today’s Session
  Benzinga · 8/17/2026
• I Underestimated Eli Lilly: Retatrutide Changes The Risk/Reward (Rating Upgrade)
  SeekingAlpha · 8/12/2026

Institutional Ownership

March 31, 2026

Total shares held

403.38M

Total value held

$14.15B

Institutional holders

1272